Innovating through embracing complexity
ND BioSciences is dedicated to pioneering next-generation therapeutics and diagnostics for neurodegenerative diseases. With a focus on treating both early and late stages of these conditions, ND BioSciences develops innovative combination therapies that prevent the initiation of pathological protein aggregation and neutralize the activities of existing protein aggregates.
Located at Route de la Corniche 5, Epalinges, Vaud 1066, CH, ND BioSciences has established integrated proprietary platforms that drive its transformative drug discovery and preclinical development programs. These platforms are built upon unique capabilities and model systems, enabling the company to reverse-engineer the complexity of protein aggregates, model key processes underlying protein pathologies and neurodegeneration in living neurons, and develop novel companion diagnostic assays and imaging agents.
ND BioSciences continues to advance the field of biotechnology research, striving to provide precision medicine solutions and improve patient outcomes. We invite the manager of ND BioSciences to create a customized and exclusive company showcase and product listing on our platform to further enhance your commercial development.
Compare ND BioSciences with 3 companies in Biotechnology-Research
| Comparison Field |
ND BioSciencesMain Company |
SyncBio TechnologiesView Profile |
AC ImmuneView Profile |
NeuronUP ENView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 0 | 2003 | 2011 |
|
Company Size
|
— | 2-10 | 51-200 | 51-200 |
|
City
|
Epalinges, Vaud | Lausanne, Vaud | Miami, Florida | |
|
Country
|
Switzerland | United States | ||
|
Skills & Keywords
Comparing with main company
|
18 Total Skills
Neurodegenerative Diseases
Therapeutics
Diagnostics
Protein Aggregation
Precision Medicine
Biotechnology Research
Drug Discovery
Neurodegenerative diseases
Huntington’s Disease
Research & Development
Synucleinopathies
Alzheimer’s Disease
Tauopathies
Amyotrophic Lateral Sclerosis
Neuroscience
Assay Development
PET Imaging
Parkinson’s Disease
|
42 Total
42 Unique
Unique Skills:
ACMG
App Development
Artificial Intelligence
Bioinformatics
Biomedicine
Biostatistics
+36
|
5 Total
5 Unique
Unique Skills:
Alzheimer's disease
Down syndrome
Misfolded proteins
Neuro-orphan diseases
Parkinson's disease
|
17 Total
17 Unique
Unique Skills:
Attention Deficit Hyperactivity Disorder (ADHD
Autism Spectrum Disorders (ASD)
Bipolar Disorder
Brain Injury
Cognitive Stimulation
Dementias
+11
|
Other organizations in the same industry
This company is also known as